2-Amino-5, 5-difluoro-5, 6-dihydro-4H-oxazines as BACE 1 and/ or BACE 2 inhibitors

Details for Australian Patent Application No. 2010330031 (hide)

Owner Siena Biotech S.p.A F. Hoffmann-La Roche AG

Inventors Banner, David; Guba, Wolfgang; Hilpert, Hans; Mauser, Harald; Mayweg, Alexander V.; Narquizian, Robert; Pinard, Emmanuel; Power, Eoin; RogersEvans, Mark; Woltering, Thomas; Wostl, Wolfgang

Agent Spruson & Ferguson

Pub. Number AU-A-2010330031

PCT Pub. Number WO2011/069934

Priority 09178983.4 11.12.09 EP

Filing date 6 December 2010

Wipo publication date 16 June 2011

International Classifications

C07D 265/08 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 31/5355 (2006.01) - Non-condensed oxazines containing further heterocyclic rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/069934 Priority application(s): WO2011/069934

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010330032-Drive assembly for a drug delivery device and drug delivery device

2010330021-Tire bead for a heavy civil engineering vehicle